Human BTLA (31-150) (M105V, G138S, V148M) Protein, Fc Tag (MALS verified), Unconjugated

Produktübersicht

• Artikelname: Human BTLA (31-150) (M105V, G138S, V148M) Protein, Fc Tag (MALS verified), Unconjugated
• Artikelnummer: ABS-BTA-H5254-100UG
• Hersteller Artikelnummer: BTA-H5254-100ug
• Alternativnummer: ABS-BTA-H5254-100UG
• Hersteller: AcroBiosystems
• Wirt: Human
• Kategorie: Proteine/Peptide
• Spezies Reaktivität: Human
• Konjugation: Unconjugated

Produktbeschreibung

B and Tlymphocyte attenuator (BTLA) is also known as B and Tlymphocyteassociated protein, CD antigen CD272. BTLA contains one Iglike Vtype (immunoglobulinlike) domain. As a lymphocyte inhibitory receptor, BTLA / CD272 inhibits lymphocytes during immune response. BTLA / CD272 can interact with tyrosine phosphatases PTPN6/SHP1 and PTPN11/SHP2, and interact with TNFRSF14/HVEM. - Proteine/Peptide

Produkteigenschaften

• Molekulargewicht: 40.2 kDa
• Tag: C-Fc
• NCBI: 44003
• Puffer: 50 mM Tris, 100 mM Glycine, 25 mM Arginine, 150 mM NaCl, pH7.5
• Expression System: Lys 31 - Ser 150
• Reinheit: 95%
• Formulierung: Powder
• Target-Kategorie: BTLA

Bilder

BTA-H5254-100ug